AC
ICVX

Aristides Capital’s Icosavax, Inc. Common Stock ICVX Stock Holding History

Aristides Capital’s Portfolio ICVX Stock Details ICVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-22,090
Closed -$156K – 209
2022
Q1 		$156K Buy
+22,090
New +$347K 0.1% 161

Other funds holding ICVX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
QUSVM
Qiming U.S. Ventures Management Bellevue, Washington $55.6M AUM 98.09% 1-Year Est. Return
ASP
Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
NanoDimension Woodside, California $24.7M AUM 74.01% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Aristides Capital's ICVX Position: Q2 2022 in Review

Aristides Capital sold out of Icosavax, Inc. Common Stock (ICVX) in Q2 2022, closing a stake of 22,090 shares — an estimated $156K sold.

Aristides Capital first reported a position in ICVX in Q1 2022 and held it in 1 quarter. The position peaked at $156K in Q1 2022. 57 funds tracked by Wall St. Rank hold ICVX as of Q2 2022.

  • Aristides Capital reported no remaining Icosavax, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Aristides Capital sold 22,090 Icosavax, Inc. Common Stock shares in Q2 2022, an estimated $156K.
  • Aristides Capital first reported a position in Icosavax, Inc. Common Stock in Q1 2022 and held it in 1 quarter.
  • Aristides Capital's Icosavax, Inc. Common Stock position peaked at $156K in Q1 2022.
  • 57 funds tracked by Wall St. Rank held Icosavax, Inc. Common Stock as of Q2 2022.

Based on Aristides Capital's 13F filing for Q2 2022, filed 15 Aug 2022.